gentle patches glp 1 reviews before and after GLP-1 Patches: What They Are, Are They Safe, Do They Actually Work? Weight Loss Injections (GLP-1) in

Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users

References & Resources FDA Basaglar Prescribing Information FDA Ozempic Prescribing Information American Diabetes Association Standards of Care 2026 Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice

A new study links GLP-1 drugs and 30-35% reduced incidence of breast cancer, using matched-pair propensity analysis ascopubs.org/doi/10.1200/OP Confirms other association studies but still no proof

Risk of cause-specific death in individuals with diabetes: a competing risks analysis

Inflammation is also known to be a key factor in the development of AS: the aggregation of white blood cells, mainly macrophages, is a significant feature of AS from its initial to its late stage (116)